CellaVision AB (publ) (OTCMKTS:CLVSF) Sees Large Drop in Short Interest

CellaVision AB (publ) (OTCMKTS:CLVSF) was the recipient of a significant decline in short interest in the month of December. As of December 15th, there was short interest totaling 11,278 shares, a decline of 21.2% from the November 30th total of 14,319 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

CellaVision AB (publ) Stock Performance

Shares of CLVSF remained flat at $16.83 during mid-day trading on Thursday. CellaVision AB has a twelve month low of $16.69 and a twelve month high of $16.83. The stock’s fifty day simple moving average is $17.41 and its 200 day simple moving average is $18.63.

About CellaVision AB (publ)

CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.

The company’s core offering revolves around its digital microscopy instruments and proprietary software.